AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated

AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated

Business Insider

Published

AstraZeneca said Thursday in updated results that its COVID-19 vaccine was still 100% effective at preventing severe disease and hospitalization.

Full Article